Cargando…
Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease
The present study aimed to describe and discuss the state of the art of biomarker use in ongoing Alzheimer’s disease (AD) research. A review of 222 ongoing phase 1, 2, 3, and 4 protocols registered in the clinicaltrials.gov database was performed. All the trials (i) enrolling subjects with clinical...
Autores principales: | Canevelli, Marco, Remoli, Giulia, Bacigalupo, Ilaria, Valletta, Martina, Toccaceli Blasi, Marco, Sciancalepore, Francesco, Bruno, Giuseppe, Cesari, Matteo, Vanacore, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564515/ https://www.ncbi.nlm.nih.gov/pubmed/32722106 http://dx.doi.org/10.3390/jpm10030068 |
Ejemplares similares
-
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF
por: Canevelli, Marco, et al.
Publicado: (2019) -
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021) -
A nationwide survey of Italian Centers for Cognitive Disorders and Dementia on the provision of care for international migrants
por: Canevelli, Marco, et al.
Publicado: (2022) -
Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
por: Lacorte, Eleonora, et al.
Publicado: (2022)